Affimed (AFMD) Revenue & Revenue Breakdown
Affimed Revenue Highlights
Latest Revenue (Y)
$8.28M
Latest Revenue (Q)
$155.00K
Main Segment (Y)
Collaboration
Main Geography (Y)
USA
Affimed Revenue by Period
Affimed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.28M | -79.99% |
| 2022-12-31 | $41.35M | 2.45% |
| 2021-12-31 | $40.37M | 42.33% |
| 2020-12-31 | $28.36M | 32.58% |
| 2019-12-31 | $21.39M | -9.88% |
| 2018-12-31 | $23.73M | 1080.85% |
| 2017-12-31 | $2.01M | -68.17% |
| 2016-12-31 | $6.31M | -16.50% |
| 2015-12-31 | $7.56M | 123.60% |
| 2014-12-31 | $3.38M | -33.52% |
| 2013-12-31 | $5.09M | 333.67% |
| 2012-12-31 | $1.17M | - |
Affimed generated $8.28M in revenue during NA 2023, up -79.99% compared to the previous quarter, and up 34.86% compared to the same period a year ago.
Affimed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $155.00K | -62.47% |
| 2023-12-31 | $413.00K | -78.95% |
| 2023-09-30 | $1.96M | 41.15% |
| 2023-06-30 | $1.39M | -69.18% |
| 2023-03-31 | $4.51M | -59.58% |
| 2022-12-31 | $11.16M | -25.05% |
| 2022-09-30 | $14.89M | 103.92% |
| 2022-06-30 | $7.30M | -8.81% |
| 2022-03-31 | $8.01M | -22.56% |
| 2021-12-31 | $10.34M | 19.35% |
| 2021-09-30 | $8.66M | -10.77% |
| 2021-06-30 | $9.71M | -16.74% |
| 2021-03-31 | $11.66M | 19.63% |
| 2020-12-31 | $9.75M | -7.58% |
| 2020-09-30 | $10.54M | 259.41% |
| 2020-06-30 | $2.93M | -42.86% |
| 2020-03-31 | $5.13M | 30.76% |
| 2019-12-31 | $3.93M | 86.73% |
| 2019-09-30 | $2.10M | -47.53% |
| 2019-06-30 | $4.01M | -64.70% |
| 2019-03-31 | $11.35M | -50.09% |
| 2018-12-31 | $22.75M | 7333.66% |
| 2018-09-30 | $306.00K | 104.00% |
| 2018-06-30 | $150.00K | -71.80% |
| 2018-03-31 | $532.00K | -16.35% |
| 2017-12-31 | $636.00K | 36.19% |
| 2017-09-30 | $467.00K | -8.07% |
| 2017-06-30 | $508.00K | 27.32% |
| 2017-03-31 | $399.00K | -70.90% |
| 2016-12-31 | $1.37M | 46.16% |
| 2016-09-30 | $938.00K | -54.66% |
| 2016-06-30 | $2.07M | 6.87% |
| 2016-03-31 | $1.94M | 16.70% |
| 2015-12-31 | $1.66M | 43.64% |
| 2015-09-30 | $1.16M | -47.74% |
| 2015-06-30 | $2.21M | -12.92% |
| 2015-03-31 | $2.54M | 3033.33% |
| 2014-12-31 | $81.00K | -95.72% |
| 2014-09-30 | $1.89M | 175.40% |
| 2014-06-30 | $687.00K | -4.85% |
| 2014-03-31 | $722.00K | -84.39% |
| 2013-12-31 | $4.63M | 2321.47% |
| 2013-09-30 | $191.00K | -4.98% |
| 2013-06-30 | $201.00K | 187.14% |
| 2013-03-31 | $70.00K | - |
Affimed generated $155.00K in revenue during Q1 2024, up -62.47% compared to the previous quarter, and up 1.39% compared to the same period a year ago.
Affimed Revenue Breakdown
Affimed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Collaboration | $7.76M | $41.20M | $39.30M | - | - |
| Service | $510.00K | $155.00K | $1.06M | - | - |
| Services | - | - | - | $605.00K | $1.71M |
| Collaboration Service | - | - | - | $27.75M | $19.68M |
Affimed's latest annual revenue breakdown by segment (product or service), as of Dec 23: Collaboration (93.84%), and Service (6.16%).
Quarterly Revenue by Product
| Product/Service | Dec 23 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|---|
| Collaboration | $6.55M | $1.22M | $7.28M | - | - | - |
| Service | $335.00K | $175.00K | $17.00K | - | - | - |
| Services | - | - | - | $222.00K | $141.00K | $325.00K |
| Collaboration Service | - | - | - | $9.48M | $2.79M | $3.68M |
Affimed's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Collaboration (95.13%), and Service (4.87%).
Affimed Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| USA | $8.27M | $41.20M | $39.62M | - | - |
| Germany | $5.00K | $152.00K | $742.00K | - | - |
| Europe | - | - | - | $2.00K | $1.65M |
| U | - | - | - | $28.16M | $19.75M |
| D | - | - | - | $194.00K | - |
Affimed's latest annual revenue breakdown by geography, as of Dec 23: USA (99.94%), and Germany (0.06%).
Quarterly Revenue by Country
| Country | Dec 23 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|---|
| USA | $6.88M | $1.39M | $7.29M | - | - | - |
| Germany | - | - | $14.00K | - | - | - |
| U | - | - | - | $9.48M | $2.93M | $3.68M |
| D | - | - | - | $222.00K | - | - |
| Europe | - | - | - | - | - | $325.00K |
Affimed's latest quarterly revenue breakdown by geography, as of Dec 23: USA (100.00%).
Affimed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AGEN | Agenus | $156.31M | $25.11M |
| ADCT | ADC Therapeutics SA | $69.56M | $17.41M |
| ADAP | Adaptimmune Therapeutics | $60.28M | $128.23M |
| PIRS | Pieris Pharmaceuticals | $42.81M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| AFMD | Affimed | $8.28M | $155.00K |
| CRVS | Corvus Pharmaceuticals | - | - |
| APTO | Aptose Biosciences | - | - |
| XFOR | X4 Pharmaceuticals | - | $560.00K |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| INZY | Inozyme Pharma | - | - |
| LPTX | Leap Therapeutics | - | - |
| ELEV | Elevation Oncology | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |